Profil
Mr. Andrew Crean is a Senior Analyst at Bernstein Autonomous LLP.
He has been analyzing UK and European insurers since 1982.
Prior to founding the firm in 2009, Mr. Crean was the head of European insurance equity research at Citigroup.
He held this post for five years, leading a team of five analysts.
Before joining Citigroup in 2000, he worked as an insurance analyst in Schroder Securities, as a partner in GVGI (a start-up institutional stockbroker) in the 1990s and at Laing & Cruickshank and Capel-Cure Myers in the 1980s.
Mr. Crean holds a BA in modern history from Oxford University.
Postes actifs de Andrew Crean
| Sociétés | Poste | Début |
|---|---|---|
Bernstein Autonomous LLP
 Bernstein Autonomous LLP Investment ManagersFinance Bernstein Autonomous LLP (dba Autonomous Research) is an investment research firm headquartered in London, UK. The firm was founded in 2009 and is a subsidiary of Sanford C. Bernstein (Autonomous UK) 1 Ltd., ultimately owned by Equitable Holdings, Inc. (NYSE: EQH) in the US. Autonomous Research provides fundamental analysis and thematic work on financial companies globally. Their clients are large institutional investors along with private equity firms, regulators, financial advisors and corporations who value the firm's research for its in-depth, intellectual approach and high quality. | Fondateur | 01/01/2009 |
Anciens postes connus de Andrew Crean
| Sociétés | Poste | Fin |
|---|---|---|
Citigroup Global Markets Ltd.
 Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Analyst-Equity | 01/05/2009 |
Capel Cure Myers Capital Management Ltd
 Capel Cure Myers Capital Management Ltd Regional BanksFinance Part of Old Mutual Ltd., Capel Cure Myers Capital Management Ltd is a securities association and international stock exchange. The company is based in London, UK. Capel Cure Myers Capital Management was acquired by OM Residual UK Ltd. on December 01, 1997 for $135.10 million. | Corporate Officer/Principal | - |
| Laing & Cruickshank Securities | Corporate Officer/Principal | - |
| Cheapside (SSL) Ltd. | Corporate Officer/Principal | - |
Formation de Andrew Crean
| University of Oxford | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Finance |
Capel Cure Myers Capital Management Ltd
Capel Cure Myers Capital Management Ltd Regional BanksFinance Part of Old Mutual Ltd., Capel Cure Myers Capital Management Ltd is a securities association and international stock exchange. The company is based in London, UK. Capel Cure Myers Capital Management was acquired by OM Residual UK Ltd. on December 01, 1997 for $135.10 million. | Finance |
| Cheapside (SSL) Ltd. | Finance |
Bernstein Autonomous LLP
Bernstein Autonomous LLP Investment ManagersFinance Bernstein Autonomous LLP (dba Autonomous Research) is an investment research firm headquartered in London, UK. The firm was founded in 2009 and is a subsidiary of Sanford C. Bernstein (Autonomous UK) 1 Ltd., ultimately owned by Equitable Holdings, Inc. (NYSE: EQH) in the US. Autonomous Research provides fundamental analysis and thematic work on financial companies globally. Their clients are large institutional investors along with private equity firms, regulators, financial advisors and corporations who value the firm's research for its in-depth, intellectual approach and high quality. | Finance |
| Laing & Cruickshank Securities |
